(603360)"Dalian BIO-CHEM Company Limited"Report for Q3 2026
Filed with SSE · Stock code 603360 · · 12 pages · Chinese
Summary by 6ix AI
The report indicates significant declines in key financial metrics, including total revenue and net profit compared to the same period last year. The company reported a net loss attributable to shareholders, reflecting challenges in its semiconductor segment and overall market conditions. The financial statements included in the report were not audited, and the company has provided assurances regarding the accuracy and completeness of the information presented.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Dalian Bio-Chem Co., Ltd. on 6ix
Earlier from Dalian Bio-Chem
- (603360)"Dalian BIO-CHEM Company Limited"Announcement on Supplementary Pledge of Shares Held by Controlling Shareholder
- (603360)"Dalian BIO-CHEM Company Limited"Announcement on Release of Pledge and Release of Freeze on Shares Held by Shareholder Holding More Than 5% of the Shares
- (603360)"Dalian BIO-CHEM Company Limited"Indicative Announcement on Judicial Compulsory Sale of Certain Shares Held by Shareholder Holding More Than 5% of the Shares and Change in Equity Interests
- (603360)"Dalian BIO-CHEM Company Limited"Announcement on Release of Pledge of Shares Held by Shareholder Holding More Than 5% of the Shares
- (603360)"Dalian BIO-CHEM Company Limited"Announcement on Judicial Compulsory Sale of Certain Shares Held by a Shareholder Holding More Than 5% of the Shares
Later from Dalian Bio-Chem
- (603360)"Dalian BIO-CHEM Company Limited"Announcement on Cumulative Repurchase of Shares through Call Auction Reaching 1%, Implementation Results and Share Changes
- (603360)"Dalian BIO-CHEM Company Limited"Pre-announcement on Convening the Q3 2026 Performance Briefing
- (603360)"Dalian BIO-CHEM Company Limited"Announcement on Progress of Performance Compensation
- (603360)"Dalian BIO-CHEM Company Limited"Announcement on Reply to the Letter of Shareholder Suggestions from the China Securities Investor Services Center
Follow Dalian Bio-Chem into a list and get an email when it puts out news.
Follow Dalian Bio-Chem